Details of the Drug

General Information of Drug (ID: DMVKL5J)

Drug Name

BI 443651

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03135899) A Two Part Phase I, Multiple-dose, Single- and Double-blind, Randomised, Double-dummy, Placebo-controlled, Four-way Crossover Study to Assess Safety and Tolerability of BI 443651 Via Respimat? Versus Placebo Via Respimat? in Subjects With Mild Asthma Following Methacholine Challenge. U.S.National Institutes of Health.